About Femtogenix
Femtogenix is a company based in London (United Kingdom) founded in 2015.. Femtogenix has raised $40.2 million across 2 funding rounds from investors including Research Corporation Technologies. The company has 14 employees as of March 31, 2022. Femtogenix operates in a competitive market with competitors including ArcherDX, Third Wave Technologies, Diagnostic Hybrids, Aptamer Group and Gen-Probe, among others.
- Headquarter London, United Kingdom
- Employees 14 as on 31 Mar, 2022
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Femtogenix Ltd.
-
Annual Revenue
-
Net Profit
$-3.52 M (USD)0as on Mar 31, 2022
-
EBITDA
-
Total Equity Funding
$40.2 M (USD)
in 2 rounds
-
Latest Funding Round
$36.63 M (USD), Series B
Mar 14, 2022
- Investors
-
Employee Count
14
as on Mar 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Femtogenix
Femtogenix has successfully raised a total of $40.2M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $36.63 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $36.6M
-
First Round
First Round
(21 Sep 2015)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2022 | Amount | Series B - Femtogenix | Valuation |
investors |
|
| Sep, 2015 | Amount | Series A - Femtogenix | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Femtogenix
Femtogenix has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Research Corporation Technologies. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Research Corporation Technologies is engaged in licensing biomedical technologies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Femtogenix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Femtogenix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Femtogenix Comparisons
Competitors of Femtogenix
Femtogenix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ArcherDX, Third Wave Technologies, Diagnostic Hybrids, Aptamer Group and Gen-Probe, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic devices and reagents are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic kits for infectious diseases are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Manufacturer of DNA and RNA nucleic acid aptamers for use in research & development
|
|
| domain | founded_year | HQ Location |
Provides clinical diagnostics, blood screening, and research products.
|
|
| domain | founded_year | HQ Location |
Bio-polymer chitosan products are developed for medical uses.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Femtogenix
Frequently Asked Questions about Femtogenix
When was Femtogenix founded?
Femtogenix was founded in 2015.
Where is Femtogenix located?
Femtogenix is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Is Femtogenix a funded company?
Femtogenix is a funded company, having raised a total of $40.2M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.57M, raised on Sep 21, 2015.
How many employees does Femtogenix have?
As of Mar 31, 2022, the latest employee count at Femtogenix is 14.
What does Femtogenix do?
Femtogenix, a spin-out company from Kings College London (KCL) is a drug discovery company focussed on developing DNA-interactive payload molecules for use in antibody-drug conjugates (ADCs). Its drug discovery platform claims to enable the design molecules which are capable of binding reversibly andor irreversibly to DNA, in a sequence-interactive manner, leading to exquisite cytotoxicity toward tumor cells and when attached to antibodies, these potent cytotoxic agents can be delivered directly to tumors. It is currently looking for a partnership with pharmaceutical companies.
Who are the top competitors of Femtogenix?
Femtogenix's top competitors include ArcherDX, Aptamer Group and KiOmed Pharma.
Who are Femtogenix's investors?
Femtogenix has 1 investor. Key investors include Research Corporation Technologies.
What is Femtogenix's valuation?
The valuation of Femtogenix is $6M as of Sep 2015.